Skip to content
Dr. Grey AI

Condition

Human Immunodeficiency Virus (HIV)

HIV is a virus that attacks the immune system, especially CD4 T cells, though antiretroviral therapy has made it a manageable long-term condition. Research has looked mostly at multivitamin-multimineral formulas, where the evidence is strong, and selenium, where it is moderate, because deficiencies are common in HIV. In one small trial of people whose CD4 counts had responded poorly, adding bovine colostrum to therapy meant CD4 counts went up. Most other findings come from small studies.

Sources: PMID 21930607

Supplements studied
14
Graded outcomes
13
Trials
20
People studied
1,059

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

14 supplements

Colostrum: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
CD4 Lymphocytes

Small Increase

Improves (the measure goes up)Small effect1 study200 people
WeightImproves (the measure goes down)5 studies121 people
Diarrhea SymptomsImproves (the measure goes down)3 studies188 people
HemoglobinImproves (the measure goes up)1 study30 people
Fatigue SymptomsImproves (the measure goes down)127 people
Fecal WeightImproves (the measure goes down)24 people
HIV Viral LoadImproves (the measure goes up)73 people

Chromium: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect6 studies46 people
WeightImproves (the measure goes down)12 studies46 people
Glycemic ControlImproves (the measure goes up)9 studies54 people
HbA1cImproves (the measure goes down)4 studies46 people
High-density lipoprotein (HDL)Improves (the measure goes up)1 study46 people

Studies that measured high-density lipoprotein (hdl)

Low-density lipoprotein (LDL)Improves (the measure goes down)1 study46 people
Total cholesterolImproves (the measure goes down)1 study46 people
Body FatImproves (the measure goes down)46 people
CD4 LymphocytesImproves (the measure goes up)8 people
HIV Viral LoadImproves (the measure goes up)8 people
TriglyceridesImproves (the measure goes down)46 people

Cannabis

  • Analgesic Use: improves
  • Ghrelin: improves
  • Leptin: improves
Cannabis: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Analgesic Use

Small Decrease

Improves (the measure goes down)Small effect4 studies34 people
GhrelinImproves (the measure goes up)2 studies7 people
LeptinImproves (the measure goes up)1 study7 people
Lymphocyte CountImproves (the measure goes up)1 study62 people

Studies that measured lymphocyte count

B Cell CountImproves (the measure goes up)62 people
CD4 LymphocytesImproves (the measure goes up)62 people
CD8 LymphocytesImproves (the measure goes up)62 people
Natural Killer Cell ActivityImproves (the measure goes up)62 people
Natural Killer Cell ContentImproves (the measure goes up)62 people
Peptide YY (PYY)Improves (the measure goes up)7 people

Spirulina

  • Glycemic Control: improves
  • Total Antioxidant Capacity (TAC): improves
  • Superoxide Dismutase Activity: improves
Spirulina: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Glycemic Control

Small Improvement

Improves (the measure goes up)Small effect1 study33 people
Total Antioxidant Capacity (TAC)Improves (the measure goes up)2 studies259 people
Superoxide Dismutase ActivityImproves (the measure goes up)184 people

Tetradecyl Thioacetic Acid

  • Apolipoprotein B: improves
  • HbA1c: improves
  • Total cholesterol: improves
Tetradecyl Thioacetic Acid: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Apolipoprotein B

Small Improvement

Improves (the measure goes down)Small effect10 people
HbA1cImproves (the measure goes down)1 study10 people
Total cholesterolImproves (the measure goes down)1 study10 people
WeightImproves (the measure goes down)1 study10 people
Glycemic ControlImproves (the measure goes up)10 people
High-density lipoprotein (HDL)Improves (the measure goes up)10 people
HIV Viral LoadImproves (the measure goes up)10 people
Kidney FunctionImproves (the measure goes up)10 people
Liver EnzymesChanges; see studies10 people
Low-density lipoprotein (LDL)Improves (the measure goes down)10 people
TNF-AlphaImproves (the measure goes down)10 people
TriglyceridesImproves (the measure goes down)10 people

Policosanol

  • High-density lipoprotein (HDL): improves
  • Low-density lipoprotein (LDL): improves
  • Total cholesterol: improves
Policosanol: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
High-density lipoprotein (HDL)

Small Improvement

Improves (the measure goes up)Small effect54 people
Low-density lipoprotein (LDL)Improves (the measure goes down)10 studies54 people
Total cholesterolImproves (the measure goes down)3 studies54 people

Fish Oil

  • C-Reactive Protein (CRP)
  • Triglycerides: improves
  • High-density lipoprotein (HDL): improves
Fish Oil: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
C-Reactive Protein (CRP)

No effect

NoneNo effect4 studies51 people
TriglyceridesImproves (the measure goes down)24 studies51 people
High-density lipoprotein (HDL)Improves (the measure goes up)7 studies51 people
Cell Adhesion FactorsImproves (the measure goes down)2 studies51 people
Low-density lipoprotein (LDL)Improves (the measure goes down)1 study51 people
Total cholesterolImproves (the measure goes down)51 people

DHEA

  • Bone Mineral Density
  • Muscle Mass: improves
  • Subjective Well-Being: improves
DHEA: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bone Mineral Density

No effect

NoneNo effect2 studies40 people
Muscle MassImproves (the measure goes up)2 studies40 people
Subjective Well-BeingImproves (the measure goes up)1 study40 people

King of Bitters

  • CD4 Lymphocytes
  • Early Virologic Response: improves
  • Liver Enzymes: changes; see studies
King of Bitters: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
CD4 Lymphocytes

No effect

NoneNo effect1 study34 people

Studies that measured cd4 lymphocytes

Early Virologic ResponseImproves (the measure goes up)17 people
Liver EnzymesChanges; see studies17 people

Guduchi

  • CD4 Lymphocytes
  • Eosinophil count: changes; see studies
  • HIV Symptoms: improves
Guduchi: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
CD4 Lymphocytes

No effect

NoneNo effect68 people
Eosinophil countChanges; see studies68 people
HIV SymptomsImproves (the measure goes down)68 people
Neutrophil CountImproves (the measure goes up)68 people
T Cell CountImproves (the measure goes up)68 people

Alanylglutamine

  • CD4 Lymphocytes
  • HIV Viral Load: improves
  • Intestinal Permeability: improves
Alanylglutamine: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
CD4 Lymphocytes

No effect

NoneNo effect37 people
HIV Viral LoadImproves (the measure goes up)1 study37 people
Intestinal PermeabilityImproves (the measure goes up)37 people
WeightChanges; see studies37 people

Guduchi

  • CD4 Lymphocytes
  • HIV Symptoms: improves
  • Eosinophil count: changes; see studies
Guduchi: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
CD4 Lymphocytes

No effect

NoneNo effect68 people
HIV SymptomsImproves (the measure goes down)1 study68 people
Eosinophil countChanges; see studies68 people
Neutrophil CountImproves (the measure goes up)68 people
T Cell CountImproves (the measure goes up)68 people

Lactobacillus reuteri

  • Bilirubin
  • Blood Pressure: improves
  • Heart Rate: improves
Lactobacillus reuteri: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bilirubin

No effect

NoneNo effect39 people
Blood PressureImproves (the measure goes down)1 study39 people
Heart RateImproves (the measure goes down)1 study39 people
TriglyceridesImproves (the measure goes down)1 study39 people
High-density lipoprotein (HDL)Improves (the measure goes up)39 people
Kidney FunctionImproves (the measure goes up)39 people
Liver EnzymesChanges; see studies39 people
Low-density lipoprotein (LDL)Improves (the measure goes down)39 people
Lymphocyte CountImproves (the measure goes up)39 people
Monocyte CountImproves (the measure goes up)39 people
Neutrophil CountImproves (the measure goes up)39 people
Red Blood Cell CountImproves (the measure goes up)39 people
Serum PlateletsImproves (the measure goes up)39 people
Total cholesterolImproves (the measure goes down)39 people
WeightImproves (the measure goes down)39 people
White Blood Cell CountImproves (the measure goes up)39 people

Alpha-Lipoic Acid

  • Oxidative Stress Biomarkers: changes; see studies
Alpha-Lipoic Acid: outcomes studied for Human Immunodeficiency Virus (HIV)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Oxidative Stress BiomarkersChanges; see studies4 studies33 people

Key findings

  • CD4 LymphocytesColostrumImproves (the measure goes up)
  • Blood glucoseChromiumImproves (the measure goes down)
  • Analgesic UseCannabisImproves (the measure goes down)

The HIV/AIDS Nutritional Support protocol

2 primary supplements · 5 supporting supplements

See the full protocol

Studies cited

100 studies from PubMed

  1. Effects of spirulina and wakame consumption on intestinal cholesterol absorption and serum lipid concentrations in non-hypercholesterolemic adult men and womenEur J Nutr, 2020 · PMID 31388739
  2. Chromium in PCOS: A Systematic Review and Meta-AnalysisClin Endocrinol, 2019 · PMID 30545267
  3. Spirulina in Health and Disease Prevention: A Comprehensive ReviewInt J Mol Sci, 2019 · PMID 30748114
  4. Chromium Supplementation and Metabolic Diseases: Evidence from Clinical TrialsJ Trace Elem Med Biol, 2018 · PMID 29691313
  5. Effects of Chromium Supplementation on Body Composition: A Systematic ReviewBiol Trace Elem Res, 2018 · PMID 30127633
  6. Safety of Chromium Supplementation: Evidence from Clinical StudiesBiol Trace Elem Res, 2018 · PMID 29851414
  7. Spirulina Supplementation and Metabolic Syndrome: A Meta-AnalysisPhytother Res, 2018 · PMID 29633990
  8. Spirulina and Allergic Rhinitis: A Systematic ReviewJ Med Food, 2018 · PMID 30315870
  9. Spirulina (Arthrospira): Nutritional Value and Health EffectsEvid Based Complement Alternat Med, 2018 · PMID 29405131
  10. Spirulina and Immune Function: A Systematic ReviewAutoimmun Rev, 2018 · PMID 30177301
  11. Safety Assessment of Spirulina (Arthrospira) as a Dietary SupplementComplement Ther Med, 2018 · PMID 29695109
  12. Effects of Chromium Supplementation on Glucose Metabolism and Lipids: A Systematic Review and Meta-AnalysisDiabetes Care, 2017 · PMID 28425499
  13. Chromium and Insulin Sensitivity: A Review of MechanismsJ Trace Elem Med Biol, 2017 · PMID 29166934
  14. Chromium Supplementation in Depression and Mood Disorders: A ReviewNutr Neurosci, 2017 · PMID 28212054
  15. Chromium Supplementation and Glycemic Control in Diabetes: An Updated ReviewIndian J Endocrinol Metab, 2017 · PMID 28586871
  16. A Systematic Review of the Effects of Spirulina on Cardiovascular Risk FactorsClin Nutr, 2017 · PMID 28182098
  17. Effects of Spirulina on Lipid Profile: A Systematic Review and Meta-AnalysisMedicine, 2017 · PMID 28849409
  18. Chromium Picolinate in Type 2 Diabetes: A Meta-Analysis of Randomized TrialsNutr Res, 2016 · PMID 27472929
  19. Chromium Effects on Blood Pressure: A Meta-AnalysisJ Hypertens, 2016 · PMID 27725073
  20. Antioxidant and Anti-Inflammatory Effects of Spirulina: Evidence from Clinical StudiesCardiovasc Ther, 2016 · PMID 27259333
  21. Effects of Spirulina on Body Weight and Blood Glucose: A Meta-AnalysisClin Nutr ESPEN, 2016 · PMID 27507219
  22. Effect of Spirulina maxima on postprandial lipemia in young runners: a preliminary reportJ Med Food, 2012 · PMID 22738038
  23. Wheat grass supplementation decreases oxidative stress in healthy subjects: a comparative study with spirulinaJ Altern Complement Med, 2007 · PMID 17983333
  24. Effects of acute chromium supplementation on postprandial metabolism in healthy young menJ Am Coll Nutr, 2004 · PMID 15310739
  25. The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjectsAm J Clin Nutr, 1985 · PMID 3898805
  26. Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older menJ Appl Physiol, 1985 · PMID 9887110
  27. Effects of bovine colostrum supplementation on immune variables in highly trained cyclistsJ Appl Physiol, 1985 · PMID 17095643
  28. IGF-I, IgA, and IgG responses to bovine colostrum supplementation during trainingJ Appl Physiol, 1985 · PMID 12133885
  29. Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during trainingJ Appl Physiol, 1985 · PMID 9338422
  30. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trialArq Gastroenterol · PMID 23657308
  31. Examination of the efficacy of acute L-alanyl-L-glutamine ingestion during hydration stress in endurance exerciseJ Int Soc Sports Nutr · PMID 20181080
  32. L-alanyl-L-glutamine ingestion maintains performance during a competitive basketball gameJ Int Soc Sports Nutr · PMID 22397703
  33. L-glutamine absorption is enhanced after ingestion of L-alanylglutamine compared with the free amino acid or wheat proteinNutr Res · PMID 22575040
  34. Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot studyJ Altern Complement Med · PMID 17604563
  35. Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementationAm J Med Genet A · PMID 21739598
  36. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patientsJ Am Coll Nutr · PMID 19571161
  37. Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose toleranceLipids Health Dis · PMID 22107734
  38. Alpha-lipoic acid supplementation: a tool for obesity therapy?Curr Pharm Des · PMID 20388095
  39. Effects of alpha-lipoic Acid on body weight in obese subjectsAm J Med · PMID 21187189
  40. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trialQJM · PMID 19273551
  41. A preliminary evaluation of a novel method to monitor a triple antioxidant combination (vitamins E, C and α-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formationEnviron Toxicol Pharmacol · PMID 21782664
  42. Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled studyAsia Pac J Clin Nutr · PMID 22374556
  43. Complementary therapy in diabetic patients with chronic complications: a pilot studyBratisl Lek Listy · PMID 20586147
  44. The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trialDiabetes Res Clin Pract · PMID 21371770
  45. Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy menBr J Clin Pharmacol · PMID 15327583
  46. Effects of Alpha-Lipoic Acid Supplementation on Inflammation, Oxidative Stress, and Serum Lipid Profile Levels in Patients with End-Stage Renal Disease on HemodialysisJ Ren Nutr · PMID 21908204
  47. Alpha-lipoic acid improves endothelial dysfunction in patients with subclinical hypothyroidismExp Clin Endocrinol Diabetes · PMID 20162509
  48. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) studyCirculation · PMID 15655130
  49. Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcomeClin Sci · PMID 18795893
  50. Effects of supplementation with alpha-lipoic acid on exercise-induced activation of coagulationMetabolism · PMID 15931620
  51. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trialDiabetes Care · PMID 21775755
  52. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trialEur J Clin Invest · PMID 20050880
  53. Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentrationInt J Sport Nutr Exerc Metab · PMID 14669930
  54. Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patientsClin Nutr · PMID 19231043
  55. The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of lifeInt J Immunopathol Pharmacol · PMID 19887043
  56. Assessment of the antioxidant effectiveness of alpha-lipoic acid in healthy men exposed to muscle-damaging exerciseJ Physiol Pharmacol · PMID 19617657
  57. Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infectionJ Altern Complement Med · PMID 18315507
  58. Efficacy of Alpha Lipoic Acid Supplementation in Sperm Parameters: A Systematic Review and Meta-Analysis of Randomized Trials.Int Braz J Urol · PMID 40327515
  59. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory studyTransl Psychiatry · PMID 32075958
  60. 1 -tetrahydrocannabinol, synhexyl and marijuana extract administered orally in man: catecholamine excretion, plasma cortisol levels and platelet serotonin contentPsychopharmacologia · PMID 5523370
  61. Acute effects of natural and synthetic cannabis compounds on prolactin levels in human malesPharmacol Biochem Behav · PMID 6320226
  62. The effects of smoked marijuana on metabolism and respiratory controlAm Rev Respir Dis · PMID 367234
  63. Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled studyAm J Clin Nutr · PMID 30949710
  64. Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in HumansCannabis Cannabinoid Res · PMID 28861511
  65. Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patientsJ Clin Pharmacol · PMID 12412840
  66. A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult menBrain Res · PMID 22133305
  67. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trialNeuropsychopharmacology · PMID 18688212
  68. Acute and residual mood and cognitive performance of young adults following smoked cannabisPharmacol Biochem Behav · PMID 32360692
  69. Effects of acute marijuana smoking on pulse rate and mood states in womenPsychopharmacology · PMID 6438677
  70. Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysisJAMA Netw Open · PMID 30646241
  71. Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trialInt J Neurosci · PMID 29792372
  72. Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosisJ Neurol · PMID 26289497
  73. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow upJ Neurol Neurosurg Psychiatry · PMID 16291891
  74. Multiple sclerosis and extract of cannabis: results of the MUSEC trialJ Neurol Neurosurg Psychiatry · PMID 22791906
  75. A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosisNeurol Res · PMID 20307378
  76. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patientsMult Scler · PMID 15327042
  77. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosisMult Scler · PMID 17086911
  78. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover studyClin Neuropharmacol · PMID 18978501
  79. A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)Mult Scler · PMID 21878454
  80. Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosisJ Neurol · PMID 22878432
  81. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialLancet · PMID 14615106
  82. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosisJ Neurol · PMID 23180178
  83. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisEur J Neurol · PMID 21362108
  84. Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trialInt J Neurosci · PMID 32065006
  85. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosisNeurology · PMID 16186518
  86. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover studyMult Scler · PMID 15327040
  87. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteersClin Pharmacol Ther · PMID 8143398
  88. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)Int Urogynecol J Pelvic Floor Dysfunct · PMID 16552618
  89. Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosisMult Scler · PMID 20829244
  90. Smoked marijuana effects on tobacco cigarette smoking behaviorJ Pharmacol Exp Ther · PMID 2319477
  91. Abstinence symptoms following smoked marijuana in humansPsychopharmacology · PMID 10090647
  92. Abstinence symptoms following oral THC administration to humansPsychopharmacology · PMID 10090646
  93. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognitionPsychopharmacology · PMID 31044290
  94. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effectsDrug Alcohol Depend · PMID 31678833
  95. Effect of cannabis use on cognitive functions and driving abilityJ Clin Psychiatry · PMID 10401919
  96. Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trialFundam Clin Pharmacol · PMID 29752828
  97. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjectsPharmacol Biochem Behav · PMID 3016764
  98. The effects of orally administered delta 9-tetrahydrocannabinol in man on mood and performance measures: a dose-response studyPharmacol Biochem Behav · PMID 2161109
  99. Opioid antagonism enhances marijuana's effects in heavy marijuana smokersPsychopharmacology · PMID 20490465
  100. Cannabis use and driving-related performance in young recreational users: a within-subject randomized clinical trialCMAJ Open · PMID 30323055